What motivates you most to engage in Alzheimer's Disease research or care at #ADPD2025?

Kicking off #ADPD2025 in Vienna! Watch Dr Juan Fortea share what he is looking forward to at the conference. #AlzheimersAwareness #ADPD40Years

Despite significant disparities in Alzheimer's Disease risk, diverse and lower-income populations remain underrepresented in research.¹ Join the discussion at #ADPD2025 about the need for inclusive Alzheimer’s disease research - because awareness drives change!

Biomarkers are an area of ongoing development in Alzheimer’s disease. Watch Prof Peter Körtvélyessy at #ADPD2025 as he elaborates on the real-world feasibility and challenges of biomarkers in Alzheimer’s disease diagnosis! #AlzheimersAwareness #ADPD40Years

What potential do biomarkers hold to transform Alzheimer’s disease diagnosis? Watch Dr Lorenzo Gaetani at #ADPD2025 as he explores the latest advancements in biomarker research. #AlzheimersAwareness #ADPD40Years

Thank you for joining #ADPD2025 in Vienna! It was amazing to connect with peers and experts. Let’s remain committed to improve the future for all those affected by Alzheimer's Disease. See you in 2026! #AlzheimersAwareness #ADPD40Years

What an incredible journey at #ADPD2025! Leading experts have shared valuable insights and explored new strategies on Alzheimer’s disease research. Watch Prof Elisabeth Stögmann reflect on key takeaways. #AlzheimersAwareness #ADPD40Years

What barriers prevent Alzheimer's Disease patients from discussing their cognitive challenges?

What is needed for a timely Alzheimer’s disease diagnosis in primary care? Prof Charlotte Teunissen highlights 3 key factors: Ongoing training, confidence in the diagnosis, and specialist support.¹⁻³ See her full response in the video! #AlzheimersAwareness

When delivering a new Alzheimer’s disease diagnosis, Dr Pascual Sánchez-Juan emphasizes the importance of empathy, understanding the family’s situation, and to communicate with care.¹,² Watch the video now! #AlzheimersAwareness

According to the 2024 Lancet Commission, there are now 14 modifiable #Dementia risk factors. Which one is newly added?

The 2024 Lancet Commission added two new modifiable risk factors for #Dementia. Can you name one?

The 2024 Lancet Commission added vision loss and high cholesterol to the list of modifiable risk factors for #Dementia - now 14 in total. Addressing these may benefit those at risk and living with dementia.¹ #AlzheimersAwareness

How is innovation improving the detection of Alzheimer's disease? Dr Fortea talks about recent advances that could support earlier and more accessible diagnosis.¹⁻³ Watch the video to learn more: #AlzheimersAwareness

May, 31st marks World No Tobacco Day. When does smoking increase the risk of #Dementia?

How are diagnostic tools for Alzheimer’s disease evolving? Prof Bonanni highlights advances in fluid biomarkers and other techniques that support accurate diagnosis.¹,² Learn more in the video: #AlzheimersAwareness

Only 2 weeks until #EAN2025 kicks off in Helsinki! We’re proud to be a sponsor of this year’s event and thrilled to be joining global neurology experts in exploring the latest advancements in Alzheimer’s disease. #AlzheimersAwareness

Be part of this expert-led symposium! Hosted by Fujirebio and Lilly, this session brings together 3 leading experts in neurology on how plasma biomarkers are shaping the clinical diagnosis of early Alzheimer’s disease. #EAN2025 #AlzheimersAwareness

Just 5 more days until #EAN2025 begins! Get ready for a long weekend of science, collaboration, and innovation in neurology. Discover the latest in Alzheimer’s disease research with experts from around the world. #AlzheimersAwareness

Conferences are a great opportunity to connect with peers. During discussions at this year’s ADPD conference, Dr. Guido Giuffrè explained how blood-based biomarkers could support early Alzheimer’s disease detection.¹⁻³ Will you join the ongoing discussion at the #EAN2025?